Ion Beam Applications SA
XBRU:IBAB

Watchlist Manager
Ion Beam Applications SA Logo
Ion Beam Applications SA
XBRU:IBAB
Watchlist
Price: 13.34 EUR -0.15% Market Closed
Market Cap: 403.9m EUR
Have any thoughts about
Ion Beam Applications SA?
Write Note

Operating Margin
Ion Beam Applications SA

6%
Current
4%
Average
4.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
6%
=
Operating Profit
27.7m
/
Revenue
465.8m

Operating Margin Across Competitors

Country BE
Market Cap 389.3m EUR
Operating Margin
6%
Country US
Market Cap 199B USD
Operating Margin
17%
Country US
Market Cap 191.3B USD
Operating Margin
26%
Country US
Market Cap 141.3B USD
Operating Margin
22%
Country US
Market Cap 134.2B USD
Operating Margin
18%
Country IE
Market Cap 104.6B USD
Operating Margin
19%
Country US
Market Cap 65.6B USD
Operating Margin
14%
Country DE
Market Cap 58.1B EUR
Operating Margin
12%
Country US
Market Cap 44.5B USD
Operating Margin
28%
Country CN
Market Cap 307.8B CNY
Operating Margin
36%
Country US
Market Cap 36.3B USD
Operating Margin
13%
No Stocks Found

Ion Beam Applications SA
Glance View

Market Cap
389.3m EUR
Industry
Health Care

Ion Beam Applications SA engages in the design, manufacture, and marketing of cancer treatment and diagnosis equipment. The company is headquartered in Louvain-La-Neuve, Brabant-Wallon. IBA is also active in the sterilization and ionization field. The firm operates through two business segments, namely the pharmaceuticals segment, which includes radiopharmaceuticals and the equipments segment, which encompasses proton therapy, particle accelerators and dosimetry. Through its various subsidiaries, Ion Beam Applications SA is active in a number of countries, including Belgium, Germany, France, Italy, Spain, the United Kingdom, Sweden, the United States, India and China. In November 2013, the Company announced the closing of the sale of 100% of its business unit Cisbio Bioassays.

IBAB Intrinsic Value
22.78 EUR
Undervaluation 41%
Intrinsic Value
Price

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
6%
=
Operating Profit
27.7m
/
Revenue
465.8m
What is the Operating Margin of Ion Beam Applications SA?

Based on Ion Beam Applications SA's most recent financial statements, the company has Operating Margin of 6%.